netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Notes:

Cardiology-related Prescribing Guidance

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

Cardiology-related Shared Care Agreements

Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter.

 

 Details...
02.03.02  Expand sub section  Drugs for arrhythmias
02.03.02  Expand sub section  Supraventricular arrhythmias
02.03.02  Expand sub section  Supraventricular and ventricular arrhythmias
Amiodarone 
(Injection)
View adult BNF View SPC online
Formulary
Red
  • Injection 150mg in 3ml
  • Pre-filled syringe 300mg in 10ml
  • Note: Should only be used where facilities for cardiac monitoring, defibrillation and cardiac pacing exist.

 

 
Link  MHRA DSU May 2015: Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone
   
Amiodarone Hydrochloride
(Oral)
View adult BNF View SPC online
Formulary
Amber
  • Tablets 100mg, 200mg
  • A Shared Care Document is in the process of being written for BSW in line with NHSE guidance (June 2019) that prescribers should not initiate amiodarone in primary care for any new patient and that if, in exceptional circumstances, there is a clinical need for amiodarone to be prescribed, this should be undertaken in a cooperation arrangement with a multi-disciplinary team and/or other healthcare professional. 
 
Link  Items which should not routinely be prescribed in primary care ; guidance for CCGs
Link  mHRA DSU May 2015: Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone
   
Disopyramide 
(Oral)
View adult BNF View SPC online
Formulary
Amber
  • Capsules 100mg
  • Tablets modified release 250mg
 
   
Flecainide 
(Oral)
View adult BNF View SPC online
Formulary
Amber
  • Tablets 50mg, 100mg
 
   
Flecainide 
(Injection)
View adult BNF View SPC online
Formulary
Red
  • Injection 150mg in 15ml
 
   
Propafenone 
(Oral)
View adult BNF View SPC online
Formulary
Amber
  • Tablets 150mg, 300mg
 
   
Sotalol  
View adult BNF View SPC online
Formulary
Amber
  • Tablets 40mg, 80mg

 

 
   
02.03.02  Expand sub section  Ventricular arrhythmias
 ....
 Non Formulary Items
Procainamide 

View adult BNF View SPC online
Non Formulary
 
Propafenone (Arthmol)

View adult BNF View SPC online
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Red

RED - Hospital only to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.  

Amber

Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.  

Amber with Shared Care

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  

Green

These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.  

Self

Suitable for patient to be directed to buy themselves  

Grey

Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.   

Black

Not currently used. We intend to include this TLS in future to highlight where a decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.  

Red Specialist Centre

Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.  

netFormulary